Executive Education
Innovation in Health Care

healthcare meeting

In a time of unprecedented transformation, healthcare organizations must find new ways to deliver better patient outcomes. 

The healthcare industry is in a period of unprecedented transformation, as technological advancements, shifting payment models and increasing caregiver burdens challenge even the most forward-thinking organizations. To keep pace with these seismic changes, healthcare organizations, pharma and biotech companies must find new ways to deliver better patient outcomes — a task that demands collaborative approaches, innovative experimentation, and the alignment of the right resources and culture within an organization. But how?

In this program, Fisher faculty and industry experts will educate and inspire participants using examples from some of the world's leading healthcare organizations’ innovative approaches to meeting these challenges head-on. Learn from these best practices so you can find strategies that fit your business model and enable you to continue pushing the boundaries of medical excellence.

At the conclusion of the program you will be able to:

  • Understand a validated model for a successful innovation process 
  • Explore the critical role of collaboration in healthcare innovation
  • Understand the emerging role of AI in healthcare and be able to discuss a specific case example from a leading healthcare organization
  • Explore lessons learned, including barriers and enablers, regarding healthcare innovation from a career of applications across industries
  • Understand recent changes in NVS drug development innovation process
  • Explore a local example of successful healthcare innovation
  • Value for Individual
    • Understand the value of collaboration across different groups for resources, new ideas, and support
    • Decrease frustration and wasted time and resources by learning how to overcome barriers to innovation

    • Enhance their leadership capabilities to mobilize and motivate teams with diverse members
  • Value for Company
    • Organizations will benefit from participants who have learned how to measure organizational innovation capability and identify gaps
    • Organizations will learn to structure contracts and collaboration modes when working with strategic partners
    • Organizations will benefit from a revival of motivation to innovate due to an increased understanding of decision-making tools

Program Details

Delivery Method Two full days, on campus and online pre-work prior to the time on campus
Program dates

Fall 2023: July 25-26, 2023

Program Schedule

Information Sessions TBD

$2,350 per participant 

Promotions and Available Discounts

  • Save $100 by registering by June 25, 2023 - use code EARLYBIRD23HEALTH

  • Discounts are available for Ohio State University employees, OSUWMC employees, Veterans, employees from non-profit organizations and organizations who send 3 or more employees.  For more information about discounts please contact Meredith Conder at conder.11@osu.edu.
Prospective Participant Profile

This program is valuable for healthcare leaders, nursing and physician administrators as well as frontline physicians and nurses. Individuals who are working in the healthcare industry such as biotech startups, life sciences, health insurers, Health IT and Accountable Care Organizations may benefit from the strategies discussed during this session. Participants may benefit from having basic knowledge of the US Health care industry.

Registration Deadline

Tuesday, July 11, 2023




Our Faculty

  • Open/Close Aravind Chandrasekaran, Professor of Operations and Business Analytics

    aravind headshotDr. Aravind Chandrasekaran (AC) is the Fisher Distinguished Professor in Operations and Business Analytics at the Fisher College of Business, The Ohio State University. He received his PhD in Operations and Management Sciences from the University of Minnesota. Dr.Chandrasekaran’s research investigates innovation, learning and knowledge creation issues in a variety of industries including high-tech R&D, manufacturing and health-care delivery. In recent years, he has begun to study the challenges involved in developing patient-centric healthcare models by conducting field experiments in collaboration with several physician and nursing leaders in the United States.  His research has been published in all top OM journals including Management Science, Manufacturing & Service Operations Management (MSOM)Journal of Operations Management, Production and Operations Management, as well as other premier journals including Information Systems Research, Journal of General Internal Medicine, Journal of Surgical Research and Harvard Business Review. His research has won several awards including the 2017 Poets and Quants 40 Under 40 Top Business School Professors in the world, 2012 INFORMS-Industry Studies Best Paper Award, 2013 Carol J. Latta Emerging Leadership Award for Outstanding Early Career Scholar by the Decision Sciences Institute and 2015 Pace Setters Award for Research.

    Dr. Chandrasekaran currently serves as the Associate Dean for Graduate Programs and Executive Education at the Fisher College of Business. He oversees all the graduate programs including Full-time MBA, Working Professional MBA, Specialized Masters as well as executive masters programs including EMBA, the Master of Business in Operational Excellence (MBOE) and non-degree executive education. He has developed several custom teaching and research programs for organizations such as Tata Consultancy Services (TCS), Ford Motor Company and Zimmer. He has won several teaching awards including the 2016 & 2012 Best Outstanding Core Professor Award (WPMBA), as well as the 2013 Pace Setter Award for Teaching Excellence.  

     In terms of external service, Dr. Chandrasekaran currently serves as the Department Editor for the Intervention-Based Research Department at JOM, and Senior Editor at POMS.  He also served as track chairs at several conferences including POMS, INFORMS and DSI. He reviews frequently for several leading academic journals including Management Science, Administrative Science Quarterly, Organization Science, MSOM, Decision Sciences and Journal of Marketing and Health Service Research.

  • Open/Close Scott Howell, Previous Chief Strategy Officer for US Pharmaceuticals at Novartis Pharmaceuticals Corporation

    scott howellScott Howell is previous Chief Strategy Officer for US Pharmaceuticals at Novartis Pharmaceuticals Corporation. In this role, Scott led a Commercial Model Transformation for Novartis, as well as US Business Development & Licensing and the Value Based Pricing & Access team. He also served as a member of the US Pharmaceuticals Executive Committee. 

    Scott joined Novartis in 2017 as VP & Head of Market Access, where he led all areas of market access including pricing and contracting, channel, managed care, hospital systems of care, as well as patient and specialty services. In this role he led very successful turnarounds placing Novartis at the forefront of the industry in these domains in the US. Prior to joining Novartis, Scott was Vice President of Market Access at Jazz Pharmaceuticals, a rare disease and orphan drug company and worked for Cardinal Health as Senior Vice President, Manufacturer and Clinical Services, Specialty Pharmaceuticals.  He also spent a number of years at Genentech where he held a variety of leadership positions in market access and clinical development.  Earlier in his career, Scott was Vice President, Pharmacy Affairs, at Highmark Blue Cross Blue Shield where he led the pharmacy program. Before Highmark, he held a variety of medical affairs and managed care leadership roles at SmithKline Beecham/GlaxoSmithKline.

    Scott began his career as a general internist and worked several years in private practice before entering academic medicine at The Ohio State University. While at Ohio State, Scott also held positions for the university in group practice administration and health plan administration.

    Scott earned his undergraduate degree at Notre Dame and his medical degree at Ohio State. He completed his medical internship and residency and also earned an MBA at Duke University. Scott has been lecturing on health policy and industry strategy for a number of years, primarily in the graduate programs at UC Berkeley, and has co-authored and contributed to a number of industry-related papers. Scott serves on several industry advisory boards and is a recognized thought leader in the area of pharmaceutical product value based pricing and access.

Cancellation and Transfer Policy

  • Open/Close Cancellation and Transfer Policy

    All cancellations and transfers must be received in writing. Submit your request via email to Jennie McAndrew at mcandrew.28@osu.edu with the name of the program, followed by “cancellation” or “transfer” in the subject line.

    • Cancellations must be made at least thirty (30) days prior to the first day of the program in order to be eligible for a full refund.
    • Cancellations must be made at least fourteen (14) days prior to the first day of the program in order to be eligible for a 50% refund.
    • Any cancellations made less than fourteen (14) days prior to the first day of the program will forfeit the registration fee.
    • If you for any reason are unable to attend the program, please consider sending someone in your place. Participants can transfer their registration to someone else within their organization at no charge up to 24 hours before the first day of the program.

Jennie McAndrew
Education Program Senior Specialist